Exelixis
EXEL
#1642
Rank
$10.25 B
Marketcap
$37.21
Share price
1.17%
Change (1 day)
56.94%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company